A detailed history of Israel Englander (Millennium Management LLC) transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 110,908 shares of APLT stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,908
Previous 926,425 88.03%
Holding current value
$1.07 Million
Previous $6.3 Million 91.79%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.04 - $6.37 $3.29 Million - $5.19 Million
-815,517 Reduced 88.03%
110,908 $517,000
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $734,370 - $2.42 Million
326,387 Added 54.39%
926,425 $6.3 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $1.02 Million - $1.85 Million
552,278 Added 1156.36%
600,038 $2.01 Million
Q2 2023

Aug 14, 2023

SELL
$0.77 - $1.8 $103,230 - $241,318
-134,066 Reduced 73.73%
47,760 $61,000
Q1 2023

May 15, 2023

BUY
$0.75 - $1.21 $89,912 - $145,058
119,883 Added 193.54%
181,826 $147,000
Q4 2022

Feb 14, 2023

SELL
$0.54 - $1.12 $20,270 - $42,042
-37,538 Reduced 37.73%
61,943 $47,000
Q3 2022

Nov 14, 2022

SELL
$0.86 - $1.55 $224,746 - $405,066
-261,333 Reduced 72.43%
99,481 $93,000
Q2 2022

Aug 15, 2022

BUY
$0.76 - $2.64 $192,065 - $667,175
252,718 Added 233.79%
360,814 $342,000
Q1 2022

May 16, 2022

BUY
$1.48 - $6.22 $55,847 - $234,711
37,735 Added 53.63%
108,096 $228,000
Q4 2021

Feb 14, 2022

BUY
$8.77 - $18.29 $512,413 - $1.07 Million
58,428 Added 489.63%
70,361 $630,000
Q3 2021

Nov 15, 2021

BUY
$13.54 - $22.06 $161,572 - $263,241
11,933 New
11,933 $198,000
Q2 2021

Aug 16, 2021

SELL
$14.05 - $25.04 $271,642 - $484,123
-19,334 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$16.57 - $28.65 $1.06 Million - $1.83 Million
-63,959 Reduced 76.79%
19,334 $363,000
Q4 2020

Feb 16, 2021

BUY
$15.44 - $24.23 $781,696 - $1.23 Million
50,628 Added 154.99%
83,293 $1.83 Million
Q3 2020

Nov 16, 2020

BUY
$19.43 - $35.36 $367,304 - $668,445
18,904 Added 137.37%
32,665 $678,000
Q2 2020

Aug 14, 2020

SELL
$29.41 - $51.23 $2.22 Million - $3.87 Million
-75,563 Reduced 84.59%
13,761 $497,000
Q1 2020

May 14, 2020

BUY
$19.54 - $55.47 $1.75 Million - $4.95 Million
89,324 New
89,324 $2.92 Million
Q4 2019

Feb 14, 2020

SELL
$10.16 - $28.14 $267,106 - $739,800
-26,290 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$8.08 - $10.99 $241,955 - $329,095
-29,945 Reduced 53.25%
26,290 $288,000
Q2 2019

Aug 14, 2019

BUY
$8.1 - $10.05 $455,503 - $565,161
56,235 New
56,235 $463,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $462M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.